Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of IPV Schedules in Latin American Infants
NCT03239496Phase 3Completed
- Sponsor
- Fighting Infectious Diseases in Emerging Countries
- Start
- Oct 2017
- Primary completion
- Nov 2018
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 3 trial of trivalent inactivated polio vaccine in poliomyelitis, sponsored by Fighting Infectious Diseases in Emerging Countries. Started Oct 2017; status: completed.
02
Drugs
trivalent inactivated polio vaccine
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on NCT03239496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03239496.